Thymidylate synthase disruption to limit cell proliferation in cell therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thymidylate synthase disruption to limit cell proliferation in cell therapies

Published:2024-08 Issue:8 Volume:32 Page:2535-2548
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Sartori-Maldonado Rocio,Montaser Hossam,Soppa Inkeri,Eurola Solja,Juutila Juhana,Balaz Melanie,Puttonen Henri,Otonkoski Timo,Saarimäki-Vire Jonna,Wartiovaara Kirmo^ORCID

Funder

Signe and Ane Gyllenberg Foundation

Finnish Cultural Foundation

Ida Mont Fundation

Bo and Kerstin Hjelt Diabetes Foundation

The Paulo Foundation

Finnish Red Cross Blood Service

Childhood Disease Research Fundation

Magnus Ehrnrooth Fundation

K Albin Johansson Foundation

Diabetes Research Foundation

HUS Group

Publisher

Elsevier BV

Reference62 articles.

1. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors;Takahashi;Cell,2007

2. Human pluripotent reprogramming with CRISPR activators;Weltner;Nat. Commun.,2018

3. Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin;Hanna;Science,2007

4. Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration;Michiko;N. Engl. J. Med.,2017

5. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells;Balboa;Nat. Biotechnol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP